These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 36557713)

  • 1. The Gut Microbiome of Children during the COVID-19 Pandemic.
    Bacorn M; Romero-Soto HN; Levy S; Chen Q; Hourigan SK
    Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the neonatal microbiome: will the pandemic cost infants their microbes?
    Romano-Keeler J; Zhang J; Sun J
    Gut Microbes; 2021; 13(1):1-7. PubMed ID: 33960272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients.
    Sun Z; Song ZG; Liu C; Tan S; Lin S; Zhu J; Dai FH; Gao J; She JL; Mei Z; Lou T; Zheng JJ; Liu Y; He J; Zheng Y; Ding C; Qian F; Zheng Y; Chen YM
    BMC Med; 2022 Jan; 20(1):24. PubMed ID: 35045853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
    Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
    Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
    Hu J; Zhang L; Lin W; Tang W; Chan FKL; Ng SC
    Trends Food Sci Technol; 2021 Feb; 108():187-196. PubMed ID: 33519087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of Oral and Gut Microbiomes in SARS-CoV-2 Infected Patients in Bangladesh: Elucidating the Role of Opportunistic Gut Microbes.
    Rafiqul Islam SM; Foysal MJ; Hoque MN; Mehedi HMH; Rob MA; Salauddin A; Tanzina AY; Biswas S; Noyon SH; Siddiki AMAMZ; Tay A; Mannan A
    Front Med (Lausanne); 2022; 9():821777. PubMed ID: 35237631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.
    Xu R; Liu P; Zhang T; Wu Q; Zeng M; Ma Y; Jin X; Xu J; Zhang Z; Zhang C
    J Genet Genomics; 2021 Sep; 48(9):803-814. PubMed ID: 34238684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
    Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
    Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
    Venzon M; Bernard-Raichon L; Klein J; Axelrad JE; Zhang C; Hussey GA; Sullivan AP; Casanovas-Massana A; Noval MG; Valero-Jimenez AM; Gago J; Putzel G; Pironti A; Wilder E; ; Thorpe LE; Littman DR; Dittmann M; Stapleford KA; Shopsin B; Torres VJ; Ko AI; Iwasaki A; Cadwell K; Schluter J
    bioRxiv; 2022 Mar; ():. PubMed ID: 35262080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
    Segal JP; Mak JWY; Mullish BH; Alexander JL; Ng SC; Marchesi JR
    Therap Adv Gastroenterol; 2020; 13():1756284820974914. PubMed ID: 33281941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
    Venzon M; Bernard-Raichon L; Klein J; Axelrad JE; Hussey GA; Sullivan AP; Casanovas-Massana A; Noval MG; Valero-Jimenez AM; Gago J; Wilder E; ; Thorpe LE; Littman DR; Dittmann M; Stapleford KA; Shopsin B; Torres VJ; Ko AI; Iwasaki A; Cadwell K; Schluter J
    Res Sq; 2021 Jul; ():. PubMed ID: 34341786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and COVID-19: An intriguing pediatric perspective.
    Valentino MS; Esposito C; Colosimo S; Caprio AM; Puzone S; Guarino S; Marzuillo P; Miraglia Del Giudice E; Di Sessa A
    World J Clin Cases; 2022 Aug; 10(23):8076-8087. PubMed ID: 36159525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity.
    Ng HY; Leung WK; Cheung KS
    Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.